Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
576 News Items found
Katharine Hsu and Rosa Sottile
Unusual Immune Cell Type Could Be Good Target for Immunotherapy

Part natural killer, part T cell, this hybrid immune cell has a “double sword” for fighting cancer.
Dana Pe'er, PhD
Sloan Kettering Institute’s Dana Pe’er Named Howard Hughes Medical Institute Investigator

Dana Pe’er, PhD, computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today.
Zhongmin Wang
Announcement
2021 Chairman’s Prize Honors Research That Paves Way for New Cell-Based Therapies to Treat Autoimmune Diseases and Inflammation

Meet Zhongmin Wang, a fifth-year doctoral student in the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), who has been awarded the 2021 Chairman’s Prize.
Direna Alonso-Curbelo, PhD
Sloan Kettering Institute’s Direna Alonso-Curbelo Named 2021 Blavatnik Regional Award for Young Scientists Winner

Direna Alonso-Curbelo, PhD, of Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), has been named a winner of the 2021 Blavatnik Regional Awards for Young Scientists in the “Life Sciences” category.
Man holding an IUD
To Detect Ovarian Cancer Early, Researchers Look to Nanotechnology

Could an implantable IUD help detect cancer early, when it is most curable? Scientists at the Sloan Kettering Institute are betting yes.
A collage of photos showing a zebrafish with GFP-labeled melanocytes, magnified GFP-labeled melanocytes, and hPSC-derived melanocytes growing in a dish.
Why Are Only Some Cells ‘Competent’ to Form Cancer? MSK Scientists Say Context Is Key

Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
MSK Study Identifies Biomarker That May Help Predict Benefits of Immunotherapy

A blood-based test identifies patients in whom immunotherapy may ‘LAG.’
Scientist Gabriela Chiosis in her lab
In the Lab
Experimental Drug Targets Misbehaving Proteins in Brain Cancer and Alzheimer’s Disease

Memorial Sloan Kettering researchers are studying how drugs that reverse malfunctioning proteins may treat disease.
Memorial Sloan Kettering surgeon Prasad Adusumilli
Q&A
CAR T Cell Therapy Shows Promise for Treating Mesothelioma

A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
MSK radiologist Andreas Wibmer
Brown Fat — Which Warms Babies and Bears — Protects Against Harmful Aspects of Obesity, Study Finds

People with small amounts of brown fat have lower risk of certain obesity-related conditions, according to a retrospective study conducted by researchers at Memorial Sloan Kettering.